With 9.9 million new cases of dementia globally each year, the type of collective action witnessed during the COVID-19 pandemic is urgently needed.
What policies, practices and partnerships can help to develop new diagnostics and treatments for Alzheimer’s?
This session is associated with the Davos Alzheimer's Collaborative, convened by the Global CEO Initiative on Alzheimer's Disease (CEOi) and the World Economic Forum.
The first part of this session is open to the public online; the second is only accessible via TopLink.